Nature-Throid — Class II drug recall D-1621-2020
Terminated recall by Preferred Pharmaceuticals, Inc., reported 2020-09-30, distributed in CA, GA. CGMP Deviations
| Recall number | D-1621-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc., Anaheim, CA, United States |
| Recall initiated | 2020-09-02 |
| Classified | 2020-09-24 |
| Reported by FDA | 2020-09-30 |
| Terminated | 2024-04-25 |
| Distributed | CA, GA |
| Reason classes | cgmp |
| NDC | 68788-9283-01 |
| Lot numbers | B2618A, C1419P, L2717G |
| Expiration dates | 2020-12-21, 2020-12-31, 2021-02-28 |
Product
Nature-Throid, 1/2 Grain, 32.5 mg (Thyroid U.S.P. 1/2 gr. (32.5 mg)/Liothyronine (T3) 4.5mcg/Levothyroxine (T4) 19mch, 100-count tablets, Rx Only, Mfg: RLC Labs; Cave Creek, AZ, Preferred Pharmaceuticals, Inc. NDC 68788-9283-01
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1621-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.